Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01286194 · ClinicalTrials.gov registry record
A Study to Investigate Use Patterns and Safety in Simulated Actual Over-the-counter (OTC) Use of Rabeprazole Sodium for the Treatment of Heartburn Symptoms
A clinical trial, sponsored by Eisai.
- Completed
- Registry status
- 1,500
- Enrollment target
NCT01286194 is a clinical trial that has completed, run by Eisai. The registered enrollment target is 1,500 participants.
The verdict
NCT01286194 has completed, sponsored by Eisai.
- COMPLETED
- Registry status
- 1,500 participants
- Enrollment target
Study Summary
This is a multi-center, open-label, all-comers OTC actual use study in pharmacy sites where the principal investigator will be a pharmacist.
Interventions
- DRUG Rabeprazole sodium
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,500 participants |
| Start Date | 2006-04 |
| Est. Completion | 2007-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01286194
The ClinicalTrials.gov registry entry for NCT01286194 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 1,500 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Eisai, which has 287 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Rabeprazole sodium is the first listed.
NCT01286194 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01286194 about?
NCT01286194 is a clinical study titled "A Study to Investigate Use Patterns and Safety in Simulated Actual Over-the-counter (OTC) Use of Rabeprazole Sodium for the Treatment of Heartburn Symptoms". This is a multi-center, open-label, all-comers OTC actual use study in pharmacy sites where the principal investigator will be a pharmacist.
What is the current status of trial NCT01286194?
This trial is currently completed. The enrollment target is 1,500 participants. The study started on 2006-04. Estimated completion is 2007-01.
What interventions are being tested in trial NCT01286194?
The interventions under investigation include: Rabeprazole sodium (DRUG).
Who is sponsoring clinical trial NCT01286194?
This trial is sponsored by Eisai, which has 287 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.